The efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia

Phase 3

• Conditions: COVID-19 disease.; Severe Acute Respiratory Syndrome coronavirus; RA01.0

• Registration Number: IRCT20200426047206N2
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Positive PCR test
Age between 18-70 years
patient with acute respiratory infectious symptoms and severe lung involvement

Exclusion Criteria

Sepsis
Pregnancy
Cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient respiratory status. Timepoint: ?????? ?? ??? ?? ????. Method of measurement: Using CT scan image, physical examination, oxygen saturation percentage.;Inflammatory factors. Timepoint: Before and two week after intervention. Method of measurement: Elisa.